Characteristics of HIV-positive patients infected by vertical transmission, Campo Grande, MS, Brazil, 1993-2009

Sexually Transmitted Infections

Volumn 88, Issue 7, 2012, Pages 525-527

  De Matos, Vanessa Terezinha Gubert ^a   De Oliveira, Ana Lúcia Lyrio ^a   De Souza, Albert Schiaveto ^a   Dal Fabbro, Márcia Maria Ferrairo Janini ^b  

^a FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^b Infectious and Parasitic Diseases Center   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CHILD; CRYPTOCOCCOSIS; DRUG TREATMENT FAILURE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; PATIENT COMPLIANCE; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEPSIS; VERTICAL TRANSMISSION;

ADOLESCENT; ANTI-HIV AGENTS; BRAZIL; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MEDICATION ADHERENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84871399871     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2011-050457     Document Type: Article

References (9)

1. Fabbro MMFJD, Moraes SPZR de, Cunha RV da, et al. Cobertura da testagem sorológica e prevalência da infecção pelo HIV entre gestantes do Estado de Mato Grosso do Sul, Brasil, 1999 a 2003. Epidemiol Serv Saude 2005;14:105-10.
2. Goetghebuer T, Haelterman E, Chenadec JL, et al. Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. AIDS 2009;23:597-604.
3. Bakanda C, Birungi J, Mwesigwa R, et al. Survival of HIV-infected adolescents on antiretroviral therapy in Uganda: findings from a Nationally Representative Cohort in Uganda. PLoS One 2011;6:e19261.
4. Machado DM, Fernandes SC, Succi RC, et al. Analysis of HIV-type 1 protease and reverse transcriptase in Brazilian children failing Highly Active Antiretroviral Therapy (HAART). Rev Inst Med Trop Sao Paulo 2005;47:1-5. (Pubitemid 40314341)
5. Lumbiganon P, Kariminia A, Aurpibul L, et al. Survival of HIV-infected children: a cohort study from the Asia-Pacific Region. J Acquir Immune Defic Syndr 2011;56:365-71.
6. Resino S, Larrú B, Bellón JM, et al. Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children. BMC Infect Dis 2006;6:1-6.
7. Diniz LM, Maia MM, Camargos LS, et al. Evaluation of long-term immunological and virological response to highly active antiretroviral therapy in a cohort of HIV infected children. HIV AIDS Rev 2011;10:70-5.
8. Chearskul P, Chokephaibulkit K, Chearskul S, et al . Effect of antiretroviral therapy in Human Immunodeficiency Virus-infected children. J Med Assoc Thai 2005;88:S221-31. (Pubitemid 43175645)
9. Bunupuradah T, Suntarattiwong P, Li A, et al. Antiretroviral treatment outcome following genotyping in Thai children who failed dual nucleoside reverse transcriptase inhibitors. Int J Infect Dis 2010;14:e311-16.